Cyteir Therapeutics
Why Robinhood?
You can watch CYTT and buy or sell other stocks, ETFs, and their options commission-free!About CYTT
Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies.
CYTT Key Statistics
Stock Snapshot
The current Cyteir Therapeutics(CYTT) stock price is $3.01, with a market capitalization of 108.35M. The stock trades at a price-to-earnings (P/E) ratio of -3.23.
On 2026-07-26, Cyteir Therapeutics(CYTT) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 645.29K.
Over the past 52 weeks, Cyteir Therapeutics(CYTT) stock has traded between a high of $3.19 and a low of $1.65.
Over the past 52 weeks, Cyteir Therapeutics(CYTT) stock has traded between a high of $3.19 and a low of $1.65.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.